Inventor · disambiguated record
Maxim Signaevsky
Also filed as: SIGNAEVSKY MAXIM
22 granted patents·2 pending applications·31 citations·filing 2003–2020
93Inventor score
Top patents by PatentIndex Score
24 records- 0188US7723312B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2005·Granted May 25, 2010·3 cites·8 claims
- 0287US7101991B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2003·Granted Sep 5, 2006·11 cites·9 claims
- 0386US7928082B2Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using sameUNIV BRITISH COLUMBIA·Filed 2008·Granted Apr 19, 2011·3 cites·5 claims
- 0486US7550580B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2006·Granted Jun 23, 2009·2 cites·6 claims
- 0584US8389491B2Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using sameGLEAVE MARTIN·Filed 2010·Granted Mar 5, 2013·2 cites·8 claims
- 0683US9580712B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2016·Granted Feb 28, 2017·1 cites·12 claims
- 0780US9101646B2Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using sameGLEAVE MARTIN·Filed 2010·Granted Aug 11, 2015·1 cites·9 claims
- 0878US8772470B1Compositions and methods for treatment of prostate and other cancersGLEAVE MARTIN·Filed 2007·Granted Jul 8, 2014·1 cites·27 claims
- 0978US7847091B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2009·Granted Dec 7, 2010·0 cites·18 claims
- 1078US7820635B2RNAi probes targeting cancer-related proteinsUNIV BRITISH COLUMBIA·Filed 2008·Granted Oct 26, 2010·2 cites·4 claims
- 1177US10602939B2Bi-directional neuron-electronic device interface structuresNEUROSILICA INC·Filed 2018·Granted Mar 31, 2020·4 cites·13 claims
- 1274US9085769B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2014·Granted Jul 21, 2015·0 cites·19 claims
- 1369US8580761B2Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using sameUNIV BRITISH COLUMBIA·Filed 2012·Granted Nov 12, 2013·0 cites·8 claims
- 1466US2016002630A1Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using SameUNIV BRITISH COLUMBIA·Filed 2015·Application pending·0 cites
- 1566US2003158143A1Bispecific antisense olignucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using sameFiled 2003·Application pending·0 cites
- 1665US9404109B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2015·Granted Aug 2, 2016·0 cites·29 claims
- 1763US8252918B2RNAi probes targeting cancer-related proteinsGLEAVE MARTIN E·Filed 2003·Granted Aug 28, 2012·1 cites·4 claims
- 1859US7964717B2RNAi probes targeting cancer-related proteinsUNIV BRITISH COLUMBIA·Filed 2006·Granted Jun 21, 2011·0 cites·21 claims
- 1958US9487777B2RNAi probes targeting cancer-related proteinsGLEAVE MARTIN·Filed 2012·Granted Nov 8, 2016·0 cites·19 claims
- 2054US8759308B2RNAi probes targeting cancer-related proteinsGLEAVE MARTIN·Filed 2010·Granted Jun 24, 2014·0 cites·15 claims
- 2153US11607161B2Bi-directional neuron-electronic device interface structuresNEUROSILICA INC·Filed 2020·Granted Mar 21, 2023·0 cites·19 claims
- 2253US8722872B2Compositions and methods for treatment of prostate and other cancersGLEAVE MARTIN E·Filed 2009·Granted May 13, 2014·0 cites·12 claims
- 2351US10845667B2Photosensitive multilayered composite material suitable for eye implantsNEUROSILICA INC·Filed 2019·Granted Nov 24, 2020·0 cites·15 claims
- 2445US11538947B2Multilayered composite material utilizing quantum dot based photovoltaic effect for bi-directional brain-computer interfaceNEUROSILICA INC·Filed 2019·Granted Dec 27, 2022·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Maxim Signaevsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →